Compounds > hydrocotarnine

hydrocotarnine and oxycodone

hydrocotarnine has been researched along with oxycodone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoka, S; Kokubun, H; Kubo, H; Matoba, M; Ouki, M; Yago, K1
Fukawa, M; Hoka, S; Kokubun, H; Matoba, M; Yago, K; Yamada, Y1
Fukawa, M; Hoka, S; Kokubun, H; Matoba, M; Nakamura, K; Yago, K1
Ikarashi, N; Ito, K; Kubota, Y; Sugiyama, K; Suto, S; Toda, T1
Akagi, T; Kudo, N; Matoba, M; Miura, K; Murakami, S; Saito, O; Sano, T; Shuto, C; Yamamoto, H; Yokote, N1

Other Studies

5 other study(ies) available for hydrocotarnine and oxycodone

ArticleYear
Determination of oxycodone and hydrocotarnine in cancer patient serum by high-performance liquid chromatography with electrochemical detection.
    Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2005, Volume: 21, Issue:3

    Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Neoplasms; Oxycodone; Tetrahydroisoquinolines

2005
Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:11

    Topics: Adult; Aged; Analgesics, Opioid; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Metabolic Clearance Rate; Middle Aged; Models, Theoretical; Neoplasms; Oxycodone; Pain; Tetrahydroisoquinolines

2007
[Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:13

    Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Tetrahydroisoquinolines

2007
Effect of hydrocotarnine on cytochrome P450 and P-glycoprotein.
    Drug metabolism and pharmacokinetics, 2009, Volume: 24, Issue:1

    Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Intestine, Small; Liver; Male; Mice; Mice, Inbred Strains; Oxycodone; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity; Tetrahydroisoquinolines

2009
[Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:5

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Retrospective Studies; Tetrahydroisoquinolines; Young Adult

2012